HPS Pharmacies wish to advise that Pfizer Australia have given notice of a possible interruption in supply of:
Prostin® E2 (dinoprostone)
2mg Vaginal Gel, 2.5mL
The supply interruption is expected to last from mid-December 2013 until late February 2014, and is the result of technical issues related to its manufacture. There are no concerns with the quality of the product.
Wholesalers still hold reasonable quantities, and HPS Pharmacies have arranged access to emergency supplies, should the need arise.
Prostin® E2 Vaginal Gel 1mg (Pfizer), ARTG 9983 is not affected by this disruption, and is not expected to suffer any shortages. Dinoprostone is also available, for the induction of labour in suitable patients, as Cervidil® Vaginal Pessary 10mg (CSL), ARTG 81391.
Please retain this notice in a prominent position, including other related business units for one month in case stock is in transit. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Pfizer Customer Service on 1800 999 543.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.